Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Dynamics of the decay of HIV RNA and distribution of bictegravir in the genital tract and rectum in antiretroviral-naïve HIV-1-infected adults treated with bictegravir/emtricitabine/tenofovir alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58).
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.
Purification of Recombinant Galectins Expressed in Bacteria.
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
New emerging targets in cancer immunotherapy: the role of neoantigens.
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction.